Introduction:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was discovered in December 2019 in Wuhan, China, and quickly gave rise to a devastating pandemic. Due to uraemia-related immune system dysfunction, pro-inammatory state , higher comorbidity burden, and the potential of cross-contamination from dialysis centres; patients on maintenance haemodialysis appear to be particularly prone to SARS-CoV-2 infection. Materials and Methods The retrospective observational study aimed to determine the clinical, biochemical, pharmacological, and radiological prognosticators of favourable outcomes in patients on maintenance haemodialysis with COVID-19 infection. It included all adult patients who were on haemodialysis therapy and were admitted to B.M.H.Gimcare hospital, Kanuur , Kerala ; with a positive real-time reverse transcription-polymerase chain reaction for SARS-CoV-2 between September 2020 to February 2021, identied from the electronic medical records system. Result: The mean age of the study's 21 males and nine females was 61.47 years; of these patients, nine succumbed to their illness. The mean age of the deceased (67.11 ± 12.34 years), dialysis vintage period (31.67 ± 7.48 months), and duration of hospital stay (13 ± 8 days) were higher than those of the survivors (59.05 ± 11.42 years, 15.71 ± 7.24 months, and 8.67 ± 4.23 days, respectively). The TLC at admission (14033.33 ± 14423.07 per µL), N/L ratio (6.27 ± 6.38), and lactate dehydrogenase serum (457.11 ± 245.26) were also signicantly higher in those who had an unfavourable outcome. All cases on femoral dialysis access succumbed to this virus. Conclusion: We postulate that the outcome will be unfavourable in COVID-19 patients on heparin-free haemodialysis via femoral access, with higher total leukocyte levels, a raised neutrophil-lymphocyte ratio, lactate dehydrogenase and quick sequential organ failure assessment scores of more than two requiring invasive ventilatory support at admission.
Read full abstract